✦ LIBER ✦

Raloxifene reduced the risk of cardiovascular events in women with osteoporosis and high cardiovascular risk

✍ Scribed by Henry Burger

Book ID: 117836781
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 70 KB
Volume: 4
Category: Article
ISSN: 1361-259X
DOI: 10.1054/ebog.2002.0075

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Raloxifene reduces risk of cardiovascula

Raloxifene reduces risk of cardiovascular events in postmenopausal women with osteoporosis

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 134 KB

Effect of Raloxifene on Cardiovascular A

Effect of Raloxifene on Cardiovascular Adverse Events in Postmenopausal Women With Osteoporosis

✍ Kristine Ensrud; Andrea Riccardo Genazzani; Mary Jane Geiger; Michelle McNabb; S 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Reducing the risk of cardiovascular dise

Reducing the risk of cardiovascular disease in older women

✍ Davey, M 📂 Article 📅 2007 🏛 Informa UK (Taylor & Francis) 🌐 English ⚖ 128 KB

Hormone replacement therapy did not redu

Hormone replacement therapy did not reduce the risk of cardiovascular events or non-cardiovascular disease outcomes in postmeopause women with CHD

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 74 KB

481 HIGH SERUM TESTOSTERONE IS ASSOCIATE

481 HIGH SERUM TESTOSTERONE IS ASSOCIATED WITH REDUCED RISK OF CARDIOVASCULAR EVENTS IN ELDERLY MEN

✍ Ohlsson, C.; Barrett-Connor, E.; Bhasin, S.; Orwoll, E.; Labrie, F.; Karlsson, M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

RANKL Inhibition With Denosumab Does Not

RANKL Inhibition With Denosumab Does Not Influence 3-Year Progression of Aortic Calcification or Incidence of Adverse Cardiovascular Events in Postmenopausal Women With Osteoporosis and High Cardiovascular Risk

✍ Samelson, Elizabeth J; Miller, Paul D; Christiansen, Claus; Daizadeh, Nadia S; G 📂 Article 📅 2014 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 352 KB